HemoCue AB, a leading innovator in point-of-care testing, is headquartered in Sweden (SE) and operates globally, with a strong presence in Europe, North America, and Asia. Founded in 1982, the company has established itself as a pioneer in the development of diagnostic solutions, particularly in the fields of haemoglobin and glucose testing.
HemoCue's core products, including the HemoCue® Hb 201+ and HemoCue® Glucose 201+, are renowned for their accuracy, ease of use, and rapid results, making them essential tools in clinical settings. The company’s commitment to quality and innovation has positioned it as a trusted partner in healthcare, contributing to improved patient outcomes worldwide. With numerous accolades and a robust market presence, HemoCue continues to lead the way in advancing diagnostic technology.
+35 vs industry average
HemoCue AB’s score of 62 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at HemoCue AB?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Machinery and Equipment has above-average carbon intensity
Industry performance
The Machinery and Equipment industry has reduced its overall emissions by 37% since 2018
Reported emissions
No reported emissions data is available for HemoCue AB yet.
HemoCue AB's reported carbon emissions
HemoCue AB, headquartered in Sweden (SE), currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Danaher Corporation, which influences its climate commitments and reporting practices.
HemoCue AB's climate initiatives and reduction targets are cascaded from Danaher Corporation. This includes adherence to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are integral to Danaher's sustainability strategy. However, specific reduction targets or achievements for HemoCue AB have not been disclosed.
As part of its corporate family, HemoCue AB aligns with Danaher Corporation's broader climate commitments, which focus on reducing greenhouse gas emissions across all scopes. The absence of specific emissions data highlights the need for ongoing transparency and accountability in climate reporting within the organisation.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
HemoCue AB’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for HemoCue AB yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Danaher Corporation
Carbon Disclosure Project
Inherited from Danaher Corporation
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Danaher Corporation
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for HemoCue AB yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project